Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Changjian LinJinwei QuanYangyang BaoWei HuaMing KeNing ZhangQi JinYun XieYue WeiTianyou LingWenqi PanLiqun WuYucai Xie

Published in: Journal of cardiovascular electrophysiology (2020)

The results suggest that both dabigatran and rivaroxaban are potential options for treating LA/LAA thrombus in patients with nonvalvular AF. Dabigatran could be an alternative option for the resolution of LA/LAA thrombus resistant to rivaroxaban.

Keyphrases

atrial fibrillation
oral anticoagulants
left atrial
left atrial appendage
catheter ablation
direct oral anticoagulants
heart failure
percutaneous coronary intervention
single molecule
venous thromboembolism
risk assessment
mitral valve
left ventricular